<DOC>
	<DOCNO>NCT02510027</DOCNO>
	<brief_summary>While broad consensus HR-HPV detection best available primary screen test , agreement efficient reliable triage procedure HR-HPV positive woman . Transient HR-HPV infection common , vast majority infection spontaneously regress year two . Only small fraction case lead persistent infection responsible cervical neoplasia . The FRIDA Study large , population-based study design evaluate performance cost-effectiveness different triage strategy hrHPV-positive woman Mexico .</brief_summary>
	<brief_title>Triage Strategies Cervical Cancer Prevention</brief_title>
	<detailed_description>The target population &lt; 100,000 woman age 30 64 year attend Cervical Cancer Screening Program 100 health center state Tlaxcala , Mexico . All woman evaluate determine hrHPV infection use CobasÂ® 4800 HPV test . Triage strategy perform reflex test hrHPV-positive participant : HPV-16/18/45 genotyping , detection E6 oncoprotein HPV-16/18 , cytology , immunocytochemistry use p16INK4a/Ki67 . Women least one positive triage test refer colposcopy evaluation , minimum four biopsy endocervical sample systematically collect . Histological confirmation perform standardized panel pathologist .</detailed_description>
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<mesh_term>Carcinoma Situ</mesh_term>
	<criteria>Women age 30 64 Residents municipality include Sanitary Jurisdiction No . 1 Tlaxcala . Pregnant hysterectomized woman Legally disable woman unable give verbal inform consent require study protocol Women wish participate present study</criteria>
	<gender>Female</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>HPV test</keyword>
	<keyword>Triage</keyword>
	<keyword>Mexico</keyword>
	<keyword>Cervical cancer screen</keyword>
</DOC>